{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:17:42Z","timestamp":1761488262416,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1080\/14653240902849770","type":"journal-article","created":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T09:06:07Z","timestamp":1244106367000},"page":"457-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization"],"prefix":"10.1016","volume":"11","author":[{"given":"Yelena","family":"Sinitsyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mandeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Grosskreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Scigliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Isola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/14653240902849770_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(96)90536-X","article-title":"Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients","volume":"347","author":"Schmitz","year":"1996","journal-title":"Lancet"},{"key":"10.1080\/14653240902849770_bib0010","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V81.8.2031.2031","article-title":"Granulocyte colony-stimulating factor \u2018mobilized\u2019 peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy","volume":"81","author":"Chao","year":"1993","journal-title":"Blood"},{"key":"10.1080\/14653240902849770_bib0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.1997.15.2.535","article-title":"Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma","volume":"15","author":"Watts","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1080\/14653240902849770_bib0020","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","article-title":"Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma","volume":"83","author":"Haas","year":"1994","journal-title":"Blood"},{"key":"10.1080\/14653240902849770_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.transci.2008.09.012","article-title":"Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients","volume":"39","author":"Mendrone","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1080\/14653240902849770_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1537-2995.2002.00010.x","article-title":"Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors","volume":"42","author":"de la Rubia","year":"2002","journal-title":"Transfusion"},{"key":"10.1080\/14653240902849770_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","article-title":"Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow","volume":"124","author":"Katayama","year":"2006","journal-title":"Cell"},{"key":"10.1080\/14653240902849770_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.bmt.1705708","article-title":"Difficult stem cell mobilization despite adequate CD34(+) cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma","volume":"40","author":"Tomblyn","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1083-8791(00)70021-8","article-title":"Favorable treatment outcome in non-Hodgkin's lymphoma patients with \u2018poor\u2019 mobilization of peripheral blood progenitor cells","volume":"6","author":"Stockerl-Goldstein","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1704486","article-title":"Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost","volume":"33","author":"Boeve","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1705147","article-title":"Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers","volume":"36","author":"Goterris","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0060","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2003-02-0440","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization","volume":"102","author":"Lemoli","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240902849770_bib0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1537-2995.2005.04222.x","article-title":"Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist","volume":"45","author":"Liles","year":"2005","journal-title":"Transfusion"},{"key":"10.1080\/14653240902849770_bib0070","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.bbmt.2008.08.011","article-title":"A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoeitic progenitor cell mobilization in patients with Hodgkin lymphoma","volume":"14","author":"Cashen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbmt.2008.11.028","article-title":"Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient","volume":"15","author":"Stiff","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bmt.1705908","article-title":"AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and\/or cytokine treatment: compassionate use data","volume":"41","author":"Calandra","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0085","first-page":"1","article-title":"Rescue from failed growth factor and\/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience","author":"Fowler","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jca.20191","article-title":"Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients","volume":"24","author":"Majado","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1080\/14653240902849770_bib0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/14653240500319135","article-title":"Innovative strategies for PBPC mobilization","volume":"7","author":"Fruehauf","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240902849770_bib0100","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2404801","article-title":"Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma","volume":"21","author":"Kumar","year":"2007","journal-title":"Leukemia"},{"key":"10.1080\/14653240902849770_bib0105","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/sj.leu.2405035","article-title":"Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients","volume":"22","author":"Mazumder","year":"2008","journal-title":"Leukemia"},{"key":"10.1080\/14653240902849770_bib0110","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.leu.2405100","article-title":"Compromised stem cell mobilization following induction therapy with lenalidomide in multiple myeloma","volume":"22","author":"Paripati","year":"2008","journal-title":"Leukemia"},{"key":"10.1080\/14653240902849770_bib0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1702514","article-title":"Blood stem cell collections in multiple myeloma: definition of a scoring system","volume":"26","author":"Corso","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/bbmt.2002.v8.pm12171483","article-title":"Transplantation of ex vivo expanded cord blood","volume":"8","author":"Shpall","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/157488807782793745","article-title":"Expansion of umbilical cord blood for clinical transplantation","volume":"2","author":"Haylock","year":"2007","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1080\/14653240902849770_bib0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1705979","article-title":"Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I\/II clinical trial","volume":"41","author":"de Lima","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240902849770_bib0135","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"key":"10.1080\/14653240902849770_bib0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity cord blood transplantation in adults","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Bone Marrow Transplant"},{"issue":"4","key":"10.1080\/14653240902849770_bib0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pbc.21882","article-title":"Pre-freeze and post-thaw characteristics on chimerism patterns in double-unit cord blood transplantation","volume":"52","author":"Jaing","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1080\/14653240902849770_bib0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1083-8791(00)70034-6","article-title":"Long-term follow-up after allogeneic granulocyte colony-stimulating factor primed bone marrow transplantation","volume":"6","author":"Isola","year":"2000","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324909702956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324909702956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:13:08Z","timestamp":1761430388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324909702956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1465324909702956"],"URL":"https:\/\/doi.org\/10.1080\/14653240902849770","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2009]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240902849770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}